Huntington initiates Janus Living stock with outperform rating

Huntington has begun covering Janus Living (NASDAQ:JAN) with an "outperform" rating and a price target of $36.00. The stock is currently trading at $31, which represents a significant 36% increase from its 52-week low and is nearing its 52-week high of $32.83. Janus Living is a healthcare real estate investment trust (REIT) that focuses on acquiring and owning senior housing operating portfolio assets throughout the United States.

The company completed its initial public offering (IPO) in March 2026, having been spun off from HealthPeak Properties, which manages Janus Living and owns nearly 70% of the REIT.

Huntington highlighted Janus Living as the sole pure-play SHOP REIT, noting its strong internal growth, lack of debt, and favorable cost of equity as key advantages. The investment firm pointed out that Janus Living holds more cash than debt on its balance sheet, with a robust current ratio of 5.88, which underscores its financial flexibility. The company's revenue of $723 million is expected to grow by 59% in fiscal 2026. However, InvestingPro analysis suggests that the stock may be overvalued relative to its fair value.

Huntington credited Janus Living's operating margin improvements as a major driver of sustained internal growth. The firm also expects acquisitions of over $1 billion in the second half of 2026 to boost external growth. Huntington noted that Janus Living provides the cleanest exposure to senior housing demographics and SHOP operating upside.

The firm also mentioned that same-store growth remains robust due to gains in rental rates, occupancy, and margins. Huntington emphasized the company's low cost of equity, which supports accretive acquisitions, and its significant balance sheet capacity to fund external growth without any debt currently outstanding or expected in the near term.